Canton Strategic Holdings (CNTN) Prepaid Assets (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Prepaid Assets of $1.6 million for Q1 2026, up 231.6% on a YoY basis from $468366.0 in Q1 2025, and up 339.58% quarter-over-quarter from $353318.0 in Q4 2025.
Canton Strategic Holdings (CNTN) Prepaid Assets (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Prepaid Assets for 7 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 231.6% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 231.6% YoY), and the FY2025 full-year result was $353318.0, up 680.59% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.6 million, up from $353318.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.6 million in Q1 2026, with the low at $11041.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $498031.1 across 5 years, with a median of $421590.0 in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets plunged 93.8% — and 2025, when it jumped 680.59%.
- Canton Strategic Holdings' Prepaid Assets stood at $178094.0 in 2022, then sank by 93.8% to $11041.0 in 2023, then soared by 309.95% to $45263.0 in 2024, then jumped by 680.59% to $353318.0 in 2025, then jumped by 339.58% to $1.6 million in 2026.
- The last three Prepaid Assets figures came in at $1.6 million (Q1 2026), $353318.0 (Q4 2025), and $89038.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 353,318.00 |
| Sep 30, 2025 | 89,038.00 |
| Jun 30, 2025 | 196,018.00 |
| Mar 31, 2025 | 468,366.00 |
| Dec 31, 2024 | 45,263.00 |
| Sep 30, 2024 | 477,009.00 |
| Jun 30, 2024 | 301,620.00 |
| Mar 31, 2024 | 460,007.00 |
| Dec 31, 2023 | 11,041.00 |
| Sep 30, 2023 | 412,890.00 |
| Jun 30, 2023 | 695,375.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 178,094.00 |
| Sep 30, 2022 | 421,590.00 |
| Jun 30, 2022 | 763,443.00 |
| Mar 31, 2022 | 969,289.00 |
| Dec 31, 2021 | 70,670.00 |
| Dec 31, 2020 | 102,946.00 |